Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Ambrisentan

Australian Public Assessment Report

AusPAR

AusPAR: Ambrisentan [PDF, 841.37 KB]

AusPAR: Ambrisentan [Word, 1.27 MB]

Attachment: Product Information: Ambrisentan [PDF, 558.63 KB]

Attachment: Product Information: Ambrisentan [Word, 1.13 MB]

Attachment: Extract from Clinical Evaluation Report Ambrisentan [PDF, 3.52 MB]

Attachment: Extract from Clinical Evaluation Report Ambrisentan [Word, 9.51 MB]

Device/Product Name

Volibris

Active ingredients

Ambrisentan

AusPAR Date

6 July 2017

Published

9 October 2017

Submission Number

PM-2014-04323-1-3

Submission Type

Extension of indications

Decision

Approved